Abstract. Radiation is one of the main treatment modalities in lung cancer, but low sensitivity and acquired resistance of lung cancer cells to radiation frequently result in treatment failure. The activation of nuclear factor (NF)-κB is reportedly the main mechanism by which cancer cells exhibit resistance to external stresses, such as chemotherapy or radiation therapy. In this study, we blocked the activation of NF-κB by adenovirusexpressing IκB·-SR and investigated the effect this had on radiation sensitivity. Transduction with ad-IκB· effectively blocked the activation of NF-κB by radiation in all the cancer cell lines tested, except for NCI H460. Clonogenic assay after radiation demonstrated that ad-IκB· transduction enhanced the sensitivity to radiation of the lung cancer cell lines and HeLa cells, except for NCI H460. The radiosensitizing effect of IκB· was more potent in lung cancer cell lines with radioresistance (SKMESres) (sensitizer enhancement ratio 1:61). From these findings, NF-κB blockade by ad-IκB· enhanced the radiation sensitivity and also abolished the acquired radiation resistance of lung cancer cell lines. This study provides a therapeutic rationale for combining an NF-κB-blocking strategy with radiation to both increase sensitivity and overcome acquired resistance to radiation.
Introduction
Radiation plays an important role in the treatment of cancer, including lung cancer. Recent guidelines from the National Comprehensive Cancer Network (NCCN) defined radiation therapy combined with chemotherapy as a standard treatment modality for stage IIIA and IIIB non-small cell lung cancer (NSCLC) (1) .
Lung cancer, particularly NSCLC, is not highly sensitive to radiation, nor is it specifically radiation resistant. However, even in cancers which are sensitive to radiation, the emergence of radiation resistance is an obstacle to the successful treatment of cancer by radiotherapy.
Acquired resistance to radiation is related to tumor repopulation (2) . However, the exact mechanisms of this resistance have yet to be fully elucidated. One possible mechanism involves the repopulation of resistant tumor cells from cancer stem cells (3) , but this theory cannot explain all the features of acquired radiation resistance, since normal cells also exhibit a similar adaptive response to radiotherapy (4). Brach et al reported that ionizing radiation induced the expression and binding activity of pre-existing nuclear factor (NF)-κB, which is a well-known anti-apoptotic cellular protein (5) .
Several studies have reported that activation of NF-κB by radiation is one of the anti-apoptotic pathways by which cancer cells display resistance to radiation. However, there are studies that report differing results on the role played by NF-κB blockade in enhancing radiation sensitivity in different cell lines. Wang et al showed that the inhibition of NF-κB enhanced apoptotic killing by ionizing radiation. (6) Russo et al also demonstrated that the inhibition of NF-κB activation by IκB· gene transfer or a proteasome inhibitor (PS-341) enhanced radiosensitivity in several cell lines (7). However, Pajonk et al reported that inhibition of NF-κB by adenovirus-IκB· failed to enhance radiosensitivity in certain cell lines (8) .
Other studies have supported the role of NF-κB in radiation resistance. Kraus et al demonstrated that the radioresistance of small-cell lung cancer, which was initially demonstrated to be radiosensitive, correlated with AKB and MAP kinase activity and increased the activation of NF-κB (9) . Inhibition of IκB· phosphorylation by a proteasome inhibitor sensitized glioma cells to radiation (10) . The proteasome inhibitor reduced the NF-κB activation induced by ionizing radiation (11) . We are interested in the role of NF-κB activation in the emergence of radiation resistance during radiation therapy for lung cancer. In this study, we used recombinant adenovirus expressing IκB· super-repressor with a mutation of 32/36 serine to alanine (ad-IκB·-SR) and lung cancer cells, including a radiation-resistant cell line established by repeated exposure to radiation. We tested the effect of ad-IκB· on enhancing radiosensitivity in human lung cancer cell lines, particularly in the lung cancer cell line with acquired resistance to radiation.
Materials and methods
Cell lines. Five human lung cancer cell lines (A549, NCI H157, NCI H358, NCI H460 and SKMES1) and one human cervical cancer cell line (HeLa) were purchased from the American Tissue Culture Collection (Manassas, VA) and Korea Cell Line Bank (Seoul, Korea). SKMESres (SKMES1 showing resistant to radiation) was generated by repeated exposure to low dose ionizing radiation (2 Gy, 8 times) in the Department of Radiation Oncology, Asan Medical Center. Cell lines were maintained in RPMI-1640 with 10% fetal bovine serum.
Recombinant adenoviruses. Recombinant adenovirus-IκB· super-repressor (ad-IκB·-SR) (S32/36A) and adenovirusLacZ (used as a control adenovirus) were generated in our laboratory. Construction of the adenoviruses was described previously (12) . The adenovirus-expressing IκB· superrepressor was fully characterized by demonstrating the blockade of TNF·-and IL-1ß-induced NF-κB activation (13) .
Transduction of lung cancer cell lines. Human lung cancer cell lines were transduced with ad-IκB· (20 moi) for 1 h in serum-free RPMI and then incubated in RPMI + 8% FBS for 24-48 h in a 5% CO 2 incubator.
Western blot assay. Production of the IκB· protein from cancer cells transduced with ad-IκB· was already confirmed by Western blot assay (14) . Briefly, A549 and NCI H157 cells were infected with ad-LacZ or ad-IκB·-SR at 20 moi. Whole cell extracts were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes 48 h after transduction, and IκB· protein was detected by rabbit polyclonal IκB· antibody (Pharmingen, San Diego, CA).
Electrophoretic mobility shift assays (EMSA).
Human lung cancer cell lines and HeLa cells were transduced with ad-IκB· (20 moi). Radiation (10 Gy) was administered by a 137 Cs irradiator after 48 h. EMSA was performed 6 h after radiation. The NF-κB double-stranded oligonucleotide corresponding to the NF-κB consensus sequence in the κ light chain enhancer in B cells (5'-AGT TGA GGG GAC TTT CCC AGG C-3') was end-labeled with [Á-32 P]ATP and T4 polynucleotide kinase. Nuclear extracts (10 μg) were added to radiolabeled NF-κB oligonucleotide (50,000-200,000 cpm) in a binding buffer. In competition experiments, a 50-fold molar excess of unlabeled oligonucleotide was added to the nuclear extracts and binding buffer, and the reaction mixture was incubated for 5 min prior to the addition of the radiolabeled probe. In supershift experiments, after the oligo-nucleotide had reacted for 20 min with the nuclear extract, 0.4 μg of anti-p65 or anti-p50 antibody was added and allowed to react for 45 min at room temperature. DNA-protein complexes were resolved on 4% nondenaturing polyacrylamide gel (80:1 acrylamide: bisacrylamide) (12, 15) .
Clonogenic assay. Human lung cancer cell lines were transduced with ad-IκB·-SR or ad-lacZ at 20 moi. After 24 h, cells were detached and irradiated with the 137 Cs irradiator for 0, 2, 4, 6 and 8 Gy. Immediately after irradiation, cells were plated in a 10-cm plate (5x10 3 cells/plate) in triplicate. After 10-14 days, colonies >2 mm in diameter were counted. The surviving fraction was normalized to the surviving fraction of the corresponding control (non-irradiated).
Results
Western blotting for IκB· production. Adenovirus-mediated gene transfer of IκB· to two lung cancer cell lines resulted in the production of the IκB· protein, as reported in our previous study (14) . The super-repressor nature of this IκB· protein has been confirmed by the demonstration of resistance to TNF·-induced degradation (13) .
Electrophoretic mobility shift assays demonstrated that the activation of NF-κB by ionizing radiation was blocked by transduction with ad-IκB·. To evaluate the effect of the overexpression of IκB·-SR on radiation-induced change in NF-κB-DNA binding activity, cells (non-transduced, ad-LacZtransduced and ad-IκB·-transduced) were irradiated at 10 Gy, and nuclear extracts were subjected to EMSA with a κB site DNA probe. In non-transduced or ad-LacZ-transduced A549, HeLa and NCI H157 cells, NF-κB-DNA binding activity increased in response to radiation. In contrast, this radiation- induced increase in NF-κB-DNA binding activity was almost completely blocked in ad-IκB·-SR-infected cells while, in NCI H460 cells, radiation failed to activate NF-κB (Fig. 1) . In two cell lines, SKMES1 and its radioresistant cell line (SKMESres), radiation induced the activation of NF-κB, which was completely blocked by prior ad-IκB· transduction (Fig. 3A) .
Clonogenic assay. The radiation doses for the surviving fraction (SF) 0.1 were 4.60 Gy in untransduced, 3.88 Gy in ad-lacZ-transduced and 3.05 Gy in ad-IκB·-transduced A549 cells. In the HeLa cell line, the doses were 5.29 Gy in untransduced, 4.71 Gy in ad-lacZ-transduced and 3.88 Gy in ad-IκB·-transduced cells. In the NCI H157 line they were 5.66 Gy in untransduced, 3.80 Gy in ad-lacZ-transduced and 2.94 Gy in ad-IκB·-transduced cells. In contrast, the radiation doses for SF 0.1 were 3.47 Gy in untransduced, 2.58 Gy in ad-lacZ-transduced and 2.58 Gy in ad-IκB·-transduced NCI H460 cells.
In A549, HeLa and NCI H157 cells, the sensitizer enhancement ratios (SERs) at SF 0.1 by ad-IκB· compared with ad-lac were 1.27, 1.21 and 1.29, respectively. However, transduction with ad-IκB· failed to increase the radiation sensitivity of NCI H460 cells (SER 1.0 compared with adlacZ), which did not display NF-κB activation by ionizing radiation (Fig. 2) .
Notably, two cell lines, SKMES and SKRESres, exhibited an enhanced sensitivity to radiation caused by prior ad-IκB· transduction. The radiation doses for SF 10 were 3.50 Gy in ad-lacZ-and 2.33 Gy in ad-IκB·-transduced SKMES1 cells (SER 1.50), and 4.16 Gy in ad-lacZ-and 2.58 Gy in ad-IκB·-transduced SKMESres cells (SER 1.61) (Fig. 3B) .
In particular, transduction with ad-IκB· markedly increased the radiation sensitivity of SKMESres compared to that of the parental cell line (SKMES1) transduced with ad-IκB·, indicating that transduction with ad-IκB· completely abolished the established resistance to radiation. These findings suggest that NF-κB activation is crucial in radiation sensitivity and established resistance to radiation.
Discussion
Non-small cell lung cancers are generally not highly sensitive to radiation. Furthermore, the emergence of resistance during the course of radiation is a common phenomenon that frequently becomes a serious obstacle to the success of radiotherapy. Many reports have supported the role of NF-κB in radiation sensitivity. The natural inhibitor of NF-κB, IκB·, and several synthetic proteasome inhibitors have been used to block NF-κB activation. Nevertheless, contradictory results make it difficult to reach a final conclusion regarding its role. Furthermore, the role of NF-κB blockade in radiation-resistant cancer cells has not been well investigated. Chen et al demonstrated that mutant IκB· transfection to block NF-κB activation was effectively reversed in radiation-resistant human keratinocytes (HK18-IR) established by repeated exposure to ionizing radiation (16) . Inhibition of NF-κB activation by adenoviral transduction of truncated IκB· markedly suppressed colon cancer growth and increased apoptosis after radiation (17) .
In this report, two notable findings are described. The first is that the differential activity of ad-IκB· was dependant on the NF-κB status of the lung cancer cell lines. EMSA revealed that radiation-induced NF-κB activation occurred in two lung cancer cell lines (A549 and NCI H157) and in a HeLa cell line. However, radiation failed to activate NF-κB in NCI H460 cells. Based on this finding, the question arose as to whether there were differences in IκB·-induced changes in radiation sensitivity according to the activation status of cellular NF-κB. As expected, IκB· treatment enhanced radiation sensitivity in only A549 and NCI H157 cells, and not in NCI H460 cells, which failed to show NF-κB activation after radiation. Kim et al had previously described that the p65 subunit of NF-κB served as a target for radiation sensitization (18) , and had demonstrated that the transfection of mutant p65 into human squamous carcinoma inhibited wild-type p65, enhanced radiosensitivity and increased radiation-induced apoptosis. Another study on the role of NF-κB p65 revealed that the increased survival of a radioresistant breast cancer cell line was related to an increased level of NF-κB p65 and the inhibition of the MEK/ERK pathway. The activation of NF-κB p65 during the emergence of adaptive radioresistance enhances cell survival by inhibiting ERK activation (19) . These findings are direct evidence that NF-κB activation is involved in radiation sensitivity.
The other important finding of the present study is that radiation resistance was reversed by ad-IκB· transduction prior to radiation. This reversal was so potent that the clonogenic survival curve of IκB·-SKMES1res was similar to that of IκB·-SKMES1 cells. This is a critical finding clinically because it indicates that the radiosensitizer effect of ad-IκB· can be extended to the radioresistant cancer cells which emerge during the course of radiation therapy. The emergence of radiation resistance during radiotherapy is the most common cause of treatment failure. These findings again demonstrate the role of IκB· gene transfer on the enhancement of radiation sensitivity and the reversal of radioresistance in lung cancer. We previously demonstrated that ad-IκB· transduction abolished the resistance of lung cancer cell lines to chemotherapy (cisplatin and adriamycin) established by longterm low-dose exposure to chemotherapeutics (14) . Therefore, NF-κB blockade by the ad-IκB· super-repressor can abolish both radioresistance and chemoresistance in lung cancer cell lines.
In conclusion, inhibition of NF-κB by ad-IκB· enhanced the radiosensitivity of human lung cancer cell lines and abolished acquired resistance to radiation. This NF-κB blockade strategy can be applied to radiation therapy in NSCLC and will help to prevent the emergence of radiation resistance. 
